Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate and coenzyme Q10 for type 2 diabetes with left ventricular diastolic dysfunction
ACTRN12606000031561Phase 2Completed
- Sponsor
- Fournier
- Start
- Jun 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of fenofibrate and coenzyme q10 in type 2 diabetes mellitus (T2DM) and left ventricular diastolic dysfunction (LVDD) (7 arms), sponsored by Fournier. Primary endpoint: E to E' ratio on cardioechocardiography. Started Jun 2003; status: completed.
02
Drugs
fenofibratecoenzyme q10
03
Conditions
type 2 diabetes mellitus (T2DM)left ventricular diastolic dysfunction (LVDD)
Beyond the preview
Go deeper on ACTRN12606000031561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000031561.